In the course of screening for new antibacterial agents, a new isolate collected from a soil sample of an arid area in south Algeria, produced a red pigment which was shown an antagonistic action against a Gram-positive bacterium Bacillus subtilis. The isolate was identified as Saccharothrix sp. and named SA 103. The red pigment, eluted by HPLC on reverse phase C18 column, contained two compounds of an anthracycline antibiotics group. The structure of the major product (2) was characterized as mutactimycin C, and PR (1) was a new member of this group, designated as mutactimycin PR. These compounds showed an antibiotic activity against certain Gram-positive bacteria in vitro. This is the first report of mutactimycins production by the genus Saccharothrix.
Antimicrobial agents are widely used in several fields: human therapy, veterinary, phytopathology, food industries and treatment of leather and wood. Many of these antibiotics are produced by microorganisms, and actinomycetes are likely the most important group of producing organismes. The Streptomyces are widely known to obtain antimicrobial agents, but over last several years, important products were obtained from other genera. One of the strategies for the screening of interesting isolates1-5) and isolation of new antimicrobial agentse6-8) is to explore unusual ecosystems such as deep sea water, hyper saline areas, arid climates, etc. Areas of south Algeria represent the widest part of Sahara and can be of interest for these objectives. The few recent studies in these areas indicated an abundance of actinomycetes in soils, and several rare genera were detected.1) In this context, and during our last study on these soils, we obtained several isolates of the genus Saccharothrix. One of these isolates, named Saccharothrix sp. SA 103, was investigated for its elaboration of a novel anthracycline antibiotic, designated as mutactimycin PR (1), and the known mutactimycin C (2) (Fig. 1) . In this paper, the taxonomy of the producing strain, fermentation, isolation and biological activities of mutactimycin PR are described. The physicochemical properties and structure elucidation of mutactimycin PR are described in the following paper.9)
Materials and Methods

Micro-organism
The producing micro-organism, strain SA 103, was by Saccharothrix sp. SA 103 is presented in Fig. 2 . The production of biological activity against B. subtilis started during the first day and peaked at day four to a stable level. The biomass increased during the first three days, remained stable, then decreased after day eight. The pH kinetic showed a little variation to alkali during the first day, then returned in the neutral, and increased at the end of the fermentation. Generally the production of secondary metabolites by micro-organisms occurs during stationary phase but in our case the production of biological activity was strongly correlated to the growth and was observed all along the culture time course. The same production kinetic has been observed for dithiolopyrrolone antibiotics production by Saccharothrix sp. SA 2336) and clavulanic acid production by Streptomyces clavuligerus.21)
Purification of Antibiotics
The different steps of antibiotics isolation and purification are summarized in Fig. 3 . Eight liters of the culture broth obtained were extracted twice with an equal volume of n-butanol to extract the entire active products.
The elution profile of the red butanolic extract on HPLC revealed two peaks, P11 and PR. The antibacterial activity of the new antibiotic PR (1) compared with mutactimycin C (2) is shown in Table 3 .
The antibiotics showed the same activity spectrum as some 
